Reuter, Uwe
Goadsby, Peter J
Lanteri-Minet, Michel
Wen, Shihua
Hours-Zesiger, Peggy
Ferrari, Michel D
Klatt, Jan
Funding for this research was provided by:
Novartis Pharma
This article is maintained by: Elsevier
Article Title: Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(18)32534-0
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(18)32606-0
Content Type: article
Copyright: © 2018 Elsevier Ltd. All rights reserved.